Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About BRIAN J. CAVENEY

Labcorp Holdings Inc. reported in an 8-K filed May 4, 2023 that BRIAN J. CAVENEY was appointed Executive Vice President, President Early Development & Chief Medical and Scientific Officer, effective May 1, 2023. The proxy statement of Labcorp Holdings Inc. reports total compensation of $3,970,629 for BRIAN J. CAVENEY in fiscal 2021, including a base salary of $521,532. Disclosed compensation is on record for 3 fiscal years.

“Labcorp announced that Brian J. Caveney, the current Executive Vice President, President, Diagnostics and Chief Medical Officer of Labcorp, a named executive officer, has been appointed to the position of Executive Vice President, President Early Development & Chief Medical and Scientific Officer, effective May 1, 2023.”
Labcorp Holdings Inc. Form 8-K, filed May 4, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Labcorp Holdings Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2021 Labcorp Holdings Inc. (LH) $521,532 $3,970,629
2020 Labcorp Holdings Inc. (LH) $505,000 $2,941,132
2019 Labcorp Holdings Inc. (LH) $462,600 $3,449,660

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.